# Nicotinamide Riboside in Systolic Heart Failure

> **NCT03423342** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 30 (actual)

## Conditions studied

- Heart Failure, Systolic

## Interventions

- **DIETARY_SUPPLEMENT:** nicotinamide riboside
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03423342
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-19
- **Primary completion:** 2019-04-11
- **Final completion:** 2019-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423342, "Nicotinamide Riboside in Systolic Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03423342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*